Paige Chamberlain
Stock Analyst at Wolfe Research
(2.05)
# 3,210
Out of 4,587 analysts
5
Total ratings
100%
Success rate
14.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paige Chamberlain
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Rated: Buy | $55 | $59.78 | -8.00% | 1 | Jun 1, 2026 | |
| NTRA Natera | Rated: Buy | $260 | $269.66 | -3.58% | 1 | Jun 1, 2026 | |
| GH Guardant Health | Rated: Buy | $150 | $152.35 | -1.54% | 1 | Jun 1, 2026 | |
| GRAL GRAIL | Initiated Coverage: Hold | n/a | $71.14 | - | 1 | Jun 1, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | n/a | $44.29 | - | 1 | Jun 1, 2026 |
Veracyte
Jun 1, 2026
Rated: Buy
Price Target: $55
Current: $59.78
Upside: -8.00%
Natera
Jun 1, 2026
Rated: Buy
Price Target: $260
Current: $269.66
Upside: -3.58%
Guardant Health
Jun 1, 2026
Rated: Buy
Price Target: $150
Current: $152.35
Upside: -1.54%
GRAIL
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $71.14
Upside: -
Tempus AI
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $44.29
Upside: -